Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis

Therapy of Lupus Nephritis

1986 • 1,163 citations

Efficacy of Mycophenolate Mofetil in Patients with Diffuse Proliferative Lupus Nephritis

2000 • 904 citations

Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis

1992 • 819 citations

Sequential Therapies for Proliferative Lupus Nephritis

2004 • 816 citations

Methylprednisolone and Cyclophosphamide, Alone or in Combination, in Patients with Lupus Nephritis

1996 • 581 citations

Long-Term Study of Mycophenolate Mofetil as Continuous Induction and Maintenance Treatment for Diffuse Proliferative Lupus Nephritis

2005 • 466 citations

Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: Lessons from long‐term followup of patients in the Euro‐Lupus Nephritis Trial

2004 • 368 citations

Factors predictive of outcome in severe lupus nephritis

2000 • 358 citations

Long‐term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only

1991 • 351 citations

Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans

1997 • 335 citations

Systemic lupus erythematosus in three ethnic groups. VIII. Predictors of early mortality in the LUMINA cohort

2001 • 324 citations

Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: Long‐term followup of a cohort of 145 patients participating in randomized controlled studies

2002 • 317 citations

Systemic Lupus Erythematosus: Emerging Concepts: Part 1: Renal, Neuropsychiatric, Cardiovascular, Pulmonary, and Hematologic Disease

1995 • 308 citations

Mycophenolate Mofetil Therapy in Lupus Nephritis

1999 • 230 citations

Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide

2000 • 227 citations

Prognosis in proliferative lupus nephritis: the role of socio-economic status and race/ethnicity

2003 • 195 citations

IMMUNOSUPPRESSIVE THERAPY IN HIGH-RISK TRANSPLANT PATIENTS

1997 • 187 citations

Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis

2004 • 185 citations

Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents

2002 • 150 citations

Mycophenolate mofetil vs cyclophosphamide therapy for patients with diffuse proliferative lupus nephritis.

2002 • 146 citations

Intermittent intravenous cyclophosphamide therapy for lupus nephritis

1989 • 117 citations

Mycophenolate mofetil for the treatment of systemic lupus erythematosus: an open pilot trial

1999 • 115 citations

Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective five-year study.

1994 • 96 citations

The safety and efficacy of MMF in lupus nephritis: a pilot study

2001 • 89 citations

Predictors of poor renal outcome in patients with lupus nephritis treated with combined pulses of cyclophosphamide and methylprednisolone

2003 • 84 citations

Mycophenolate mofetil in lupus glomerulonephritis

2002 • 55 citations

MYCOPHENOLATE MOFETIL REDUCES THE RISK OF ACUTE REJECTION LESS IN AFRICAN-AMERICAN THAN IN CAUCASIAN KIDNEY RECIPIENTS1

1998 • 46 citations

Equivalence trials in SLE research: issues to consider

1999 • 20 citations

Cyclophosphamide therapy for lupus nephritis: poor renal survival in Arab children

2003 • 18 citations

Prolonged follow-up of patients with diffuse proliferative lupus nephritis (DPLN) treated with prednisolone and mycophenolate mofetil (MMF)

2001 • 15 citations

Outcome of Chilean Patients with Lupus Nephritis and Response to Intravenous Cyclophosphamide

2003 • 11 citations

Deleted Work

1955 • 0 citations